2023-06-01 2024-05-31 false Capium Accounts Production 1.1 14083647 2023-06-01 2024-05-31 14083647 bus:AbridgedAccounts 2023-06-01 2024-05-31 14083647 bus:FRS102 2023-06-01 2024-05-31 14083647 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 14083647 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 14083647 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 14083647 2023-06-01 2024-05-31 14083647 2024-05-31 14083647 bus:RegisteredOffice 2023-06-01 2024-05-31 14083647 core:WithinOneYear 2024-05-31 14083647 core:AfterOneYear 2024-05-31 14083647 1 2023-06-01 2024-05-31 14083647 bus:Director1 2023-06-01 2024-05-31 14083647 bus:Director1 2024-05-31 14083647 bus:Director1 2022-05-03 2023-05-31 14083647 2022-05-03 14083647 bus:LeadAgentIfApplicable 2023-06-01 2024-05-31 14083647 2022-05-03 2023-05-31 14083647 2023-05-31 14083647 core:WithinOneYear 2023-05-31 14083647 core:AfterOneYear 2023-05-31 14083647 bus:EntityAccountantsOrAuditors 2022-05-03 2023-05-31 14083647 core:ComputerEquipment 2023-06-01 2024-05-31 14083647 core:ComputerEquipment 2024-05-31 14083647 core:ComputerEquipment 2023-05-31 14083647 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-05-31 14083647 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-05-31 14083647 core:CostValuation core:Non-currentFinancialInstruments 2024-05-31 14083647 core:CostValuation core:Non-currentFinancialInstruments 2023-05-31 14083647 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-05-31 14083647 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-05-31 14083647 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-05-31 14083647 core:Non-currentFinancialInstruments 2024-05-31 14083647 core:Non-currentFinancialInstruments 2023-05-31 14083647 core:ShareCapital 2024-05-31 14083647 core:ShareCapital 2023-05-31 14083647 core:RetainedEarningsAccumulatedLosses 2024-05-31 14083647 core:RetainedEarningsAccumulatedLosses 2023-05-31 14083647 dpl:Item1 2023-06-01 14083647 dpl:Item1 2024-05-31 14083647 dpl:Item1 2022-05-03 14083647 dpl:Item1 2023-05-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 14083647
England and Wales

 

 

 

MTK PHARMA CONSULTING LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 June 2023

End date: 31 May 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 192    335 
192    335 
Current assets      
Debtors 8,649    12,144 
Cash at bank and in hand 26,312    23,210 
34,961    35,354 
Creditors: amount falling due within one year (9,009)   (15,509)
Net current assets 25,952    19,845 
 
Total assets less current liabilities 26,144    20,180 
Net assets 26,144    20,180 
 

Capital and reserves
     
Called up share capital 1    1 
Profit and loss account 26,143    20,179 
Shareholders' funds 26,144    20,180 
 


For the year ended 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the profit and loss account has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 24 January 2025 and were signed by:


-------------------------------
Karthik BOYAPATI
Director
1
General Information
MTK PHARMA CONSULTING LIMITED is a private company, limited by shares, registered in England and Wales, registration number 14083647, registration address 31, GREENWAY ROAD, HEALD GREEN, CHEADLE, England, SK8 3NR.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 3 years Straight Line
2.

Average number of employees

Average number of employees during the year was 2 (2023 : 0).
3.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 01 June 2023 429    429 
Additions  
Disposals  
At 31 May 2024 429    429 
Depreciation
At 01 June 2023 94    94 
Charge for year 143    143 
On disposals  
At 31 May 2024 237    237 
Net book values
Closing balance as at 31 May 2024 192    192 
Opening balance as at 01 June 2023 335    335 


2